Combining these upregulated genes with survival information from TCGA lung adenocarcinoma cases confirmed that higher TP53 mutation signature scores were associated with a worse prognosis compared with lower signature scores (Figure 4, G). This evidence concerns the gene TP53 and lung adenocarcinoma.